Summary of Purpose
To collect additional confirmatory data on alteplase(rt-PA) in the European setting and to demonstrate that the treatment of patients between 3 and 4.30 hours of onset of symptoms of acute ischemic stroke with rt-PA compared to placebo-treated patients will result in an improved clinical outcome without increase of fatality rate.Read More →
The following dates are available for this trial. Trial information last updated on 30 April 2014.
|1 Apr 2003||9 Sep 2005||1 Feb 2008||Unavailable||1 Apr 2014||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Purpose: Treatment
Bertrand Baumelou, MD Head of Clinical Research Unit Neurovascular, Immunology, Virology BI France 12, Rue André Huet, BP 292 F-51060 Reims cedex Tel: 00 33 326 50 87 04 Fax: 00 33 326 50 38 email@example.com